glp 1 and ckd Nephroprotective effects of GLP-1 receptor agonists: where do we stand? | Journal of Nephrology TrimRX | Custom GLP-1 Dosing
Description
With Transcend, Lilly had a full picture of data, to the point that they published the data in The Lancet, but the trial was only 40 weeks long and multiple endpoints including A1c, weight loss and other markers havent quite hit the full potential of the drug for diabetics so were left with questions on what happens when you take it for a longer term

All of these studies are observational, meaning that their findings can't establish cause and effect

Staying hydrated is important
How do I handle food aversions on GLP-1

Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become essential medications in the management of type 2 diabetes mellitus and obesity due to their ability to improve glucose control and facilitate weight loss by enhancing insulin secretion, reducing glucagon release, and slowing gastric emptying

Understanding Compounded Semaglutide The GLP-1 telehealth industry is currently under significant regulatory scrutiny
